RD Lewis Holdings’s Quest Diagnostics DGX Stock Holding History

RD Lewis Holdings’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$455K	Hold	2,298	–	–	0.39%	53
2025 Q4	$426K	Sell	2,298 -5	-0.2%	-$910	0.36%	60
2025 Q3	$430K	Sell	2,303 -300	-12%	-$53.2K	0.4%	55
2025 Q2	$454K	Sell	2,603 -28	-1%	-$4.86K	0.46%	55
2025 Q1	$468K	Sell	2,631 -70	-3%	-$11.5K	0.53%	48
2024 Q4	$439K	Buy	+2,701	New	+$420K	0.48%	51

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

RD Lewis Holdings's DGX Position: Q1 2026 in Review

RD Lewis Holdings held its Quest Diagnostics (DGX) position steady in Q1 2026 at 2,298 shares worth $455K. The position accounts for 0.39% of the portfolio, ranked #53.

RD Lewis Holdings first reported a position in DGX in Q4 2024 and has held it in 6 quarters since. The position peaked at $468K in Q1 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

RD Lewis Holdings held 2,298 shares of Quest Diagnostics worth $455K as of Q1 2026.
RD Lewis Holdings left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up 0.39% of RD Lewis Holdings's portfolio in Q1 2026, its #53 holding.
RD Lewis Holdings first reported a position in Quest Diagnostics in Q4 2024 and has held it in 6 quarters since.
RD Lewis Holdings's Quest Diagnostics position peaked at $468K in Q1 2025.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on RD Lewis Holdings's 13F filing for Q1 2026, filed 14 Apr 2026.